Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00044447 · ClinicalTrials.gov registry record · Phase 3

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

A Phase 3 study of Diabetes Mellitus, Non-Insulin-Dependent, sponsored by Sanofi.

Completed
Registry status
Phase 3
Development phase
170
Enrollment target
1
Study location

NCT00044447 is a Phase 3 study of Diabetes Mellitus, Non-Insulin-Dependent that has completed, run by Sanofi. The registered enrollment target is 170 participants, below the 210-participant average among 5 other Diabetes Mellitus, Non-Insulin-Dependent trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00044447, a Phase 3 study of Diabetes Mellitus, Non-Insulin-Dependent, has completed, sponsored by Sanofi.

COMPLETED
Registry status
Phase 3
Development phase
170 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the efficacy and safety of Amaryl when added to Metformin and Thiazolidinedione (TZD) in non-insulin dependent diabetes mellitus (NIDDM) patients.

Conditions Studied

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

  • DRUG Glimepiride

Study Locations (1)

Texas

  • Dallas Diabetes & Endocrine Center - Dallas

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2001-05
Est. Completion 2002-09
Phase Phase 3

Sponsor

Sanofi

713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00044447

The ClinicalTrials.gov registry entry for NCT00044447 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 5 other Diabetes Mellitus, Non-Insulin-Dependent trials with a reported enrollment target (19% lower). The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Non-Insulin-Dependent appearing as the primary indexed condition, and to 1 intervention - of which Glimepiride is the first listed.

NCT00044447 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00044447 about?

NCT00044447 is a clinical study titled "Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione". The purpose of this study is to assess the efficacy and safety of Amaryl when added to Metformin and Thiazolidinedione (TZD) in non-insulin dependent diabetes mellitus (NIDDM) patients.

What is the current status of trial NCT00044447?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 170 participants. The study started on 2001-05. Estimated completion is 2002-09.

What conditions does trial NCT00044447 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Non-Insulin-Dependent.

What interventions are being tested in trial NCT00044447?

The interventions under investigation include: Glimepiride (DRUG).

Who is sponsoring clinical trial NCT00044447?

This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00044447 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Non-Insulin-Dependent

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Non-Insulin-Dependent

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.